Insiders who reported open-market trades in the last 12 months at the companies Neha Krishnamohan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Neha Krishnamohan is a corporate insider, tracked as Director of Arcutis Biotherapeutics, Inc. (ARQT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Neha Krishnamohan last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 4 filings going back to 2025.
Has Neha Krishnamohan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($939K) across all tracked filings.
Neha Krishnamohan is Director of Arcutis Biotherapeutics, Inc. (ARQT). 4 SEC Form 4 filings on record going back to 2025, most recently on 10 June 2026. Most recent open-market trade: sold $29K of ARQT on 17 November 2025. Lifetime open-market sales: $939K.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Neha Krishnamohan.
InsiderAlpha's records for Neha Krishnamohan go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
